Price
CHART BY
Frequently asked questions
What is PacBio's market capitalization?
The market capitalization of PacBio is $421.75M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for PacBio?
PacBio's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.137. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for PacBio's stock?
Currently, 16 analysts cover PacBio's stock, with a consensus target price of $2.538. Analyst ratings provide insights into the stock's expected performance.
What is PacBio's revenue over the trailing twelve months?
Over the trailing twelve months, PacBio reported a revenue of $154.01M.
What is the free float of PacBio's shares?
The free float of PacBio is 243.13M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $421.75M
- EPS (TTM)
- -$1.137
- Free Float
- 243.13M
- Revenue (TTM)
- $154.01M
Pricing
- 1D span
- $1.527$1.706
- 52W span
- $1.16$6.08
Analyst Ratings
The price target is $2.538 and the stock is covered by 16 analysts.
Buy
7
Hold
9
Sell
0
Information
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US69404D1081
- Primary Ticker
- PACB
Knockouts
Finance data from FactSet